Authors: ETIEVANT C SCHAMBEL P GUMINSKI Y BARRET JM IMBERT T HILL BT

Citation: C. Etievant et al., REQUIREMENTS FOR P-GLYCOPROTEIN RECOGNITION BASED ON STRUCTURE-ACTIVITY-RELATIONSHIPS IN THE PODOPHYLLOTOXIN SERIES, Anti-cancer drug design, 13(4), 1998, pp. 317-336

Authors: LAMOTHE M PAUWELS PJ BELLIARD K SCHAMBEL P HALAZY S

Citation: M. Lamothe et al., DIFFERENTIATION BETWEEN PARTIAL AGONISTS AND NEUTRAL 5-HT1B ANTAGONISTS BY CHEMICAL MODULATION OF PYL]-4-HYDROXY-N-[4-(PYRIDIN-4-YL)PHENYL]BENZAMIDE (GR-55562), Journal of medicinal chemistry, 40(22), 1997, pp. 3542-3550

Authors: CASTAN F SCHAMBEL P ENRICI A ROLLAND F BIGG DCH

Citation: F. Castan et al., NEW ARYLPIPERAZINE DERIVATIVES WITH HIGH-AFFINITY FOR 5-HT3 RECEPTOR-SITES, Medicinal chemistry research, 6(2), 1996, pp. 81-101

Authors: GAILLARD P CARRUPT PA TESTA B SCHAMBEL P

Citation: P. Gaillard et al., BINDING OF ARYLPIPERAZINES, (ARYLOXY)PROPANOLAMINES, AND TETRAHYDROPYRIDYLINLDOLES TO THE 5-HT1A RECEPTOR - CONTRIBUTION OF THE MOLECULAR LIPOPHILICITY POTENTIAL TO 3-DIMENSIONAL QUANTITATIVE STRUCTURE-AFFINITY RELATIONSHIP MODELS, Journal of medicinal chemistry, 39(1), 1996, pp. 126-134